Erratum

Phase I/II trial of HIV-1 hyperimmune globulin for the prevention of HIV-1 vertical transmission in Uganda Laura A. Guay, Philippa Musoke, David L. Hom, Clemensia Nakabiito, Danstan Bagenda, Courtney V. Fletcher, Lawrence H. Marum, Mary Glenn Fowler, Lars G. Falksveden, Britta Wahren, Peter Kataaha, Hans Wigzell, Francis A. Mmiro and J. Brooks Jackson

AIDS 2002, 16:1391-1400

On page 1394, 2nd column, 2nd paragraph the author incorrectly stated: Measurement of HIV-1 p24 antibody was performed by Quest Laboratories (Baltimore, Maryland, USA) using a specific competitive EIA (Envacore) [28].

The correct statement should read: Measurement of HIV-1 p24 antibody was performed by Quest Diagnostics (Baltimore, Maryland, USA) using the HIVAB p24 (rDNA) enzyme immunoassay (Abbott Laboratories), not the Envacore assay from Abbott Laboratories. The correct reference for the HIVAB p24 (rDNA) enzyme immunoassay is: Mofenson LM, Lambert JS, Stiehm ER et al. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. N Engl J Med 1999, 314: 385-389